These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 34224329)

  • 61. Sustained QT prolongation induced by tacrolimus in guinea pigs.
    Minematsu T; Ohtani H; Sato H; Iga T
    Life Sci; 1999; 65(14):PL197-202. PubMed ID: 10530807
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Novel concentration-QTc models for early clinical studies with parallel placebo controls: A simulation study.
    Orihashi Y; Kumagai Y; Shiosakai K
    Pharm Stat; 2021 Mar; 20(2):375-389. PubMed ID: 33295138
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of Age and Sex on the QTc Interval in Children and Adolescents With Type 1 and 2 Long-QT Syndrome.
    Vink AS; Clur SB; Geskus RB; Blank AC; De Kezel CC; Yoshinaga M; Hofman N; Wilde AA; Blom NA
    Circ Arrhythm Electrophysiol; 2017 Apr; 10(4):. PubMed ID: 28356306
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Use of ANOVA to estimate inter- and intra-reader variability for a group of readers in thorough QT/QTc studies.
    Natekar M; Mahajan V; Satra A; O'Kelly M; Karnad DR
    Clin Pharmacol Ther; 2008 Mar; 83(3):489-91. PubMed ID: 18183035
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Drug-induced QT prolongation: Concordance of preclinical anesthetized canine model in relation to published clinical observations for ten CiPA drugs.
    Koshman YE; Wilsey AS; Bird BM; Endemann AL; Sadilek S; Treadway J; Martin RL; Polakowski JS; Gintant GA; Mittelstadt SW
    J Pharmacol Toxicol Methods; 2020; 103():106871. PubMed ID: 32360993
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Operational Characteristics of Linear Concentration-QT Models for Assessing QTc Interval in the Thorough QT and Phase I Clinical Studies.
    Garnett C; Needleman K; Liu J; Brundage R; Wang Y
    Clin Pharmacol Ther; 2016 Aug; 100(2):170-8. PubMed ID: 26946218
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of liver transplantation on QT-interval prolongation and impact on mortality.
    Ko J; Koshy AN; Han HC; Weinberg L; Gow P; Testro A; Lim HS; Farouque O; Teh AW
    Int J Cardiol; 2021 Mar; 326():158-163. PubMed ID: 33186663
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
    Mayet S; Gossop M; Lintzeris N; Markides V; Strang J
    Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Meperidine-induced QTc-interval prolongation: prevalence, risk factors, and correlation to plasma drug and metabolite concentrations
.
    Keller GA; Villa Etchegoyen MC; Fernández N; Olivera NM; Quiroga PN; Diez RA; Di Girolamo G
    Int J Clin Pharmacol Ther; 2017 Mar; 55(3):275-285. PubMed ID: 27509828
    [TBL] [Abstract][Full Text] [Related]  

  • 70. ILSI-HESI cardiovascular safety subcommittee dataset: an analysis of the statistical properties of QT interval and rate-corrected QT interval (QTc).
    Chiang AY; Bass AS; Cooper MM; Engwall MJ; Menton RG; Thomas K
    J Pharmacol Toxicol Methods; 2007; 56(2):95-102. PubMed ID: 17588780
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Phase 1 summary of plasma concentration-QTc analysis for idasanutlin, an MDM2 antagonist, in patients with advanced solid tumors and AML.
    Blotner S; Chen LC; Ferlini C; Zhi J
    Cancer Chemother Pharmacol; 2018 Mar; 81(3):597-607. PubMed ID: 29392451
    [TBL] [Abstract][Full Text] [Related]  

  • 72. QT PRODACT: in vivo QT assay in the conscious dog for assessing the potential for QT interval prolongation by human pharmaceuticals.
    Toyoshima S; Kanno A; Kitayama T; Sekiya K; Nakai K; Haruna M; Mino T; Miyazaki H; Yano K; Yamamoto K
    J Pharmacol Sci; 2005; 99(5):459-71. PubMed ID: 16493187
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Medical toxicologists' practice patterns regarding drug-induced QT prolongation in overdose patients: a survey in the United States of America, Europe, and Asia Pacific region.
    Othong R; Devlin JJ; Kazzi ZN
    Clin Toxicol (Phila); 2015 May; 53(4):204-9. PubMed ID: 25706450
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Drug-Induced QTc Interval Prolongation: A Multicenter Study to Detect Drugs and Clinical Factors Involved in Every Day Practice.
    Keller GA; Alvarez PA; Ponte ML; Belloso WH; Bagnes C; Sparanochia C; Gonzalez CD; Villa Etchegoyen MC; Diez RA; Di Girolamo G
    Curr Drug Saf; 2016; 11(1):86-98. PubMed ID: 26537523
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Halothane-anaesthetized, closed-chest, guinea-pig model for assessment of drug-induced QT-interval prolongation.
    Sakaguchi Y; Takahara A; Nakamura Y; Akie Y; Sugiyama A
    Basic Clin Pharmacol Toxicol; 2009 Jan; 104(1):43-8. PubMed ID: 18699795
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Correction for QT/RR hysteresis in the assessment of drug-induced QTc changes--cardiac safety of gadobutrol.
    Malik M; Hnatkova K; Schmidt A; Smetana P
    Ann Noninvasive Electrocardiol; 2009 Jul; 14(3):242-50. PubMed ID: 19614635
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Emergency department approach to QTc prolongation.
    Pourmand A; Mazer-Amirshahi M; Chistov S; Sabha Y; Vukomanovic D; Almulhim M
    Am J Emerg Med; 2017 Dec; 35(12):1928-1933. PubMed ID: 28855066
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Potential strategy for assessing QT/QTc interval for drugs that produce rapid changes in heart rate: Electrocardiographic assessment of the effects of intravenous remimazolam on cardiac repolarization.
    Kleiman RB; Darpo B; Thorn M; Stoehr T; Schippers F
    Br J Clin Pharmacol; 2020 Aug; 86(8):1600-1609. PubMed ID: 32144789
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Serum albumin level and abnormal corrected QT interval in patients with coronary artery disease and chronic kidney disease.
    Wu CC; Lu YC; Yu TH; Wang CP; Hung WC; Tang WH; Tsai IT; Chung FM; Lee YJ; Hu JJ
    Intern Med J; 2018 Oct; 48(10):1242-1251. PubMed ID: 29573083
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Use of a novel transfer function to reduce repolarization interval hysteresis.
    Halámek J; Jurák P; Bunch TJ; Lipoldová J; Novák M; Vondra V; Leinveber P; Plachy M; Kara T; Villa M; Frána P; Soucek M; Somers VK; Asirvatham SJ
    J Interv Card Electrophysiol; 2010 Oct; 29(1):23-32. PubMed ID: 20625805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.